Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics

Overview

Journal Curr Osteoporos Rep

Publisher Current Science

Specialties Endocrinology
Orthopedics

Date 2017 Apr 28

PMID 28447312

Citations 37

Authors

Erin M B McNerny

Thomas L Nickolas

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: In this paper, we review the epidemiology, diagnosis, and pathogenesis of fractures and renal osteodystrophy.

Recent Findings: The role of bone quality in the pathogenesis of fracture susceptibility in chronic kidney disease (CKD) is beginning to be elucidated. Bone quality refers to bone material properties, such as cortical and trabecular microarchitecture, mineralization, turnover, microdamage, and collagen content and structure. Recent data has added to our understanding of the effects of CKD on alterations to bone quality, emerging data on the role of abnormal collagen structure on bone strength, the potential of non-invasive methods to inform our knowledge of bone quality, and how we can use these methods to inform strategies that protect against bone loss and fractures. However, more prospective data is required. CKD is associated with abnormal bone quality and strength which results in high fracture incidence.

Citing Articles

Use of 3D-DXA in the assessment of bone structure among patients with chronic kidney disease.

Kuzma M, Kuzmova Z, Humbert L, Picazo M, Kralik R, Falat J Front Med (Lausanne). 2025; 12:1471418.

PMID: 39967597 PMC: 11832544. DOI: 10.3389/fmed.2025.1471418.

Evaluation of complications in patients with mandible fractures undergoing chronic kidney disease in the United States.

Zhao L, Zhu L, Yang D, Xie H, Ma L BMC Oral Health. 2024; 24(1):1116.

PMID: 39300467 PMC: 11414127. DOI: 10.1186/s12903-024-04903-5.

Knowledge, attitude, and practice toward osteoporosis among patients with chronic kidney disease in Zhejiang.

Xu P, Zhao N, Wang J Medicine (Baltimore). 2024; 103(20):e38153.

PMID: 38758880 PMC: 11098230. DOI: 10.1097/MD.0000000000038153.

Patellar and quadriceps tendon rupture are associated with hip fracture in hemodialysis patients with severe hyperparathyroidism.

Pichone A, Juvencio E, Crespo B, Gomes C, Mendes R, Godinho M JBMR Plus. 2024; 8(2):ziae008.

PMID: 38505521 PMC: 10945730. DOI: 10.1093/jbmrpl/ziae008.

Microvascular disease not type 2 diabetes is associated with increased cortical porosity: A study of cortical bone microstructure and intracortical vessel characteristics.

Loffler M, Wu P, Pirmoazen A, Joseph G, Stewart J, Saeed I Bone Rep. 2024; 20:101745.

PMID: 38444830 PMC: 10912053. DOI: 10.1016/j.bonr.2024.101745.

References

Sosa D, Vilaplana L, Guerri R, Nogues X, Wang-Fagerland M, Diez-Perez A . Are the High Hip Fracture Rates Among Norwegian Women Explained by Impaired Bone Material Properties?. J Bone Miner Res. 2015; 30(10):1784-9. DOI: 10.1002/jbmr.2537. View

Vautour L, Melton 3rd L, Clarke B, Achenbach S, Oberg A, McCarthy J . Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int. 2003; 15(2):160-7. DOI: 10.1007/s00198-003-1532-y. View

Yenchek R, Ix J, Shlipak M, Bauer D, Rianon N, Kritchevsky S . Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol. 2012; 7(7):1130-6. PMC: 3386677. DOI: 10.2215/CJN.12871211. View

Arneson T, Li S, Liu J, Kilpatrick R, Newsome B, St Peter W . Trends in hip fracture rates in US hemodialysis patients, 1993-2010. Am J Kidney Dis. 2013; 62(4):747-54. DOI: 10.1053/j.ajkd.2013.02.368. View

Akaberi S, Simonsen O, Lindergard B, Nyberg G . Can DXA predict fractures in renal transplant patients?. Am J Transplant. 2008; 8(12):2647-51. DOI: 10.1111/j.1600-6143.2008.02423.x. View

Isakova T, Craven T, Scialla J, Nickolas T, Schnall A, Barzilay J . Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial. Bone. 2015; 78:23-7. PMC: 4466209. DOI: 10.1016/j.bone.2015.04.037. View

Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K . Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006; 69(11):1945-53. DOI: 10.1038/sj.ki.5000414. View

Mellibovsky L, Prieto-Alhambra D, Mellibovsky F, Guerri-Fernandez R, Nogues X, Randall C . Bone Tissue Properties Measurement by Reference Point Indentation in Glucocorticoid-Induced Osteoporosis. J Bone Miner Res. 2015; 30(9):1651-6. DOI: 10.1002/jbmr.2497. View

Couttenye M, DHaese P, Van Hoof V, Lemoniatou E, Goodman W, Verpooten G . Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients. Nephrol Dial Transplant. 1996; 11(6):1065-72. View

10.

Furst J, Bandeira L, Fan W, Agarwal S, Nishiyama K, McMahon D . Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes. J Clin Endocrinol Metab. 2016; 101(6):2502-10. PMC: 4891790. DOI: 10.1210/jc.2016-1437. View

11.

Jamal S, Cheung A, West S, Lok C . Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease. Osteoporos Int. 2012; 23(12):2805-13. DOI: 10.1007/s00198-012-1908-y. View

12.

Naylor K, McArthur E, Leslie W, Fraser L, Jamal S, Cadarette S . The three-year incidence of fracture in chronic kidney disease. Kidney Int. 2014; 86(4):810-8. DOI: 10.1038/ki.2013.547. View

13.

Bala Y, Seeman E . Bone's Material Constituents and their Contribution to Bone Strength in Health, Disease, and Treatment. Calcif Tissue Int. 2015; 97(3):308-26. DOI: 10.1007/s00223-015-9971-y. View

14.

Trombetti A, Stoermann C, Chevalley T, van Rietbergen B, Herrmann F, Martin P . Alterations of bone microstructure and strength in end-stage renal failure. Osteoporos Int. 2012; 24(5):1721-32. DOI: 10.1007/s00198-012-2133-4. View

15.

Lehmann G, Stein G, Huller M, Schemer R, Ramakrishnan K, Goodman W . Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry. Kidney Int. 2005; 68(3):1206-14. DOI: 10.1111/j.1523-1755.2005.00513.x. View

16.

Akkus O, Adar F, Schaffler M . Age-related changes in physicochemical properties of mineral crystals are related to impaired mechanical function of cortical bone. Bone. 2004; 34(3):443-53. DOI: 10.1016/j.bone.2003.11.003. View

17.

Dooley A, Weiss N, Kestenbaum B . Increased risk of hip fracture among men with CKD. Am J Kidney Dis. 2007; 51(1):38-44. DOI: 10.1053/j.ajkd.2007.08.019. View

18.

Bervoets A, Spasovski G, Behets G, Dams G, Polenakovic M, Zafirovska K . Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients. Am J Kidney Dis. 2003; 41(5):997-1007. DOI: 10.1016/s0272-6386(03)00197-5. View

19.

Herberth J, Branscum A, Mawad H, Cantor T, Monier-Faugere M, Malluche H . Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study. Am J Kidney Dis. 2010; 55(5):897-906. PMC: 2882243. DOI: 10.1053/j.ajkd.2009.12.041. View

20.

Vashishth D, Gibson G, Khoury J, Schaffler M, Kimura J, Fyhrie D . Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone. 2001; 28(2):195-201. DOI: 10.1016/s8756-3282(00)00434-8. View